Evaluation of the impact of arginine-chitosan/DNA nanoparticles on human naive CD4+ T cells

Journal of Biomedical Materials Research - Part A

Volumn 96 A, Issue 1, 2011, Pages 170-176

  Liu, Lanxia ^a   Bai, Yuanyuan ^a   Zhu, Dunwan ^a   Song, Liping ^a   Wang, Hai ^a   Dong, Xia ^a   Zhang, Hailing ^a   Leng, Xigang ^a  

^a INSTITUTE OF BIOMEDICAL ENGINEERING   (China)

Author keywords

arginine; chitosan; gene delivery; naive CD4+ T cell; nanoparticle

Indexed keywords

ARGININE; CYTOKINES; DNA NANOPARTICLES; GENE DELIVERY; IMMUNE CELLS; LIPOPOLYSACCHARIDES; MACROPHAGE-STIMULATING ACTIVITY; SEMI-PERMEABLE MEMBRANES; T CELLS; TRANS-GENES;

AMINO ACIDS; CHITIN; CHITOSAN; CYTOLOGY; GENE THERAPY; GENE TRANSFER; NANOPARTICLES;

CELLS;

ARGININE; CHITOSAN; DNA; GAMMA INTERFERON; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; NANOPARTICLE; POLYCARBONATE; RECOMBINANT PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROMOLECULE; MACROPHAGE FUNCTION; PROTEIN EXPRESSION;

ARGININE; BIOCOMPATIBLE MATERIALS; CD4-POSITIVE T-LYMPHOCYTES; CHITOSAN; CYTOKINES; DNA; ENDOCYTOSIS; HUMANS; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MATERIALS TESTING; NANOPARTICLES; T-LYMPHOCYTE SUBSETS;

EID: 78649586732     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32966     Document Type: Article

References (35)

1. Bloomfield VA,. DNA condensation. Curr Opin Struct Biol 1996; 6: 334-341.
2. MacLaughlin FC, Mumper RJ, Wang J, Tagliaferri JM, Gill I, Hinchcliffe M, Rolland AP,. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Control Release 1998; 56: 259-272.
3. Richardson SC, Kolbe HV, Duncan R,. Potential of low molecular mass chitosan as a DNA delivery system: Biocompatibility, body distribution and ability to complex and protect DNA. Int J Pharm 1999; 178: 231-243.
4. Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, August JT, Leong KW,. Chitosan-DNA nanoparticles as gene carriers: Synthesis, characterization and transfection efficiency. J Control Release 2001; 70: 399-421.
5. Erbacher P, Zou S, Bettinger T, Steffan AM, Remy JS,. Chitosan-based vector/DNA complexes for gene delivery: Biophysical characteristics and transfection ability. Pharm Res 1998; 15: 1332-1339.
6. Corsi K, Chellat F, Yahia L, Fernandes JC,. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials 2003; 24: 1255-1264.
7. Guang Liu W, De Yao K,. Chitosan and its derivatives-a promising non-viral vector for gene transfection. J Control Release 2002; 83: 1-11.
8. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM,. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 2004; 100: 5-28.
9. Mansouri S, Lavigne P, Corsi K, Benderdour M, Beaumont E, Fernandes JC,. Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: Strategies to improve transfection efficacy. Eur J Pharm Biopharm 2004; 57: 1-8.
10. Kaplan IM, Wadia JS, Dowdy SF,. Cationic TAT peptide transduction domain enters cells by macropinocytosis. J Control Release 2005; 102: 247-253.
11. Cardarelli F, Serresi M, Bizzarri R, Giacca M, Beltram F,. In vivo study of HIV-1 Tat arginine-rich motif unveils its transport properties. Mol Ther 2007; 15: 1313-1322.
12. Binder H, Lindblom G,. A molecular view on the interaction of the trojan peptide penetratin with the polar interface of lipid bilayers. Biophys J 2004; 87: 332-343.
13. Zheng C, Brownlie R, Babiuk LA, van Drunen Littel-van den Hurk S,. Characterization of the nuclear localization and nuclear export signals of bovine herpesvirus 1 VP22. J Virol 2005; 79: 11864-11872.
14. Gupta B, Torchilin VP,. Transactivating transcriptional activator-mediated drug delivery. Exp Opin Drug Deliv 2006; 3: 177-190.
15. Rudolph C, Plank C, Lausier J, Schillinger U, Muller RH, Rosenecker J,. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J Biol Chem 2003; 278: 11411-11418.
16. van Rossenberg SM, van Keulen AC, Drijfhout JW, Vasto S, Koerten HK, Spies F, van't Noordende JM, van Berkel TJ, Biessen EA,. Stable polyplexes based on arginine-containing oligopeptides for in vivo gene delivery. Gene Ther 2004; 11: 457-464.
17. Zhu D, Zhang H, Bai J, Liu W, Leng X, Song C, Yang J, Li X, Jin X, Song L,. Enhancement of transfection efficiency for HeLa cells via incorporating arginine moiety into chitosan. Chin Sci Bull 2007; 52: 3207-3215.
18. Liu L, Bai Y, Song C, Zhu D, Song L, Zhang H, Dong X, Leng X,. The impact of arginine-modified chitosan-DNA nanoparticles on the function of macrophages. J Nanopart Res 2010; 12: 1637-1644.
19. Zenewicz LA, Antov A, Flavell RA,. CD4 T-cell differentiation and inflammatory bowel disease. Trends Mol Med 2009; 15: 199-207.
20. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT,. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-1132.
21. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK,. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-238.
22. Muranski P, Boni A, Antony PA, Cassard L, Irvine KR, Kaiser A, Paulos CM, Palmer DC, Touloukian CE, Ptak K, Gattinoni L, Wrzesinski C, Hinrichs CS, Kerstann KW, Feigenbaum L, Chan CC, Restifo NP,. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 2008; 112: 362-373.
23. Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP, Shah B, Chang SH, Schluns KS, Watowich SS, Feng XH, Jetten AM, Dong C,. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008; 29: 44-56.
24. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT,. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006; 441: 231-234.
25. Liu L, Song C, Song L, Zhang H, Dong X, Leng X,. Effects of alkylated-chitosan-DNA nanoparticles on the function of macrophages. J Mater Sci: Mater Med 2009; 20: 943-948.
26. Watford WT, Moriguchi M, Morinobu A, O'shea JJ,. The biology of IL-12: Coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 2003; 14: 361-368.
27. Feili-Hariri M, Falkner DH, Morel PA,. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: Implications for immunotherapy. J Leukoc Biol 2005; 78: 656-664.
28. Seferian PG, Martinez ML,. Immune stimulating activity of two new chitosan containing adjuvant formulations. Vaccine 2000; 19: 661-668.
29. Bivas-Benita M, van Meijgaarden KE, Franken KL, Junginger HE, Borchard G, Ottenhoff TH, Geluk A,. Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A0201-restricted T-cell epitopes of Mycobacterium tuberculosis. Vaccine 2004; 22: 1609-1615.
30. Li F, Wang L, Jin XM, Yan CH, Jiang S, Shen XM,. The immunologic effect of TGF-β1 chitosan nanoparticle plasmids on ovalbumin-induced allergic BALB/c mice. Immunobiology 2009; 214: 87-99.
31. Chellat F, Grandjean-Laquerriere A, Le Naour R, Fernandes J, Yahia L, Guenounou M, Laurent-Maquin D,. Metalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticles. Biomaterials 2005; 26: 961-970.
32. Cong YP, Song SS, Bhagat L, Pandey RK, Yu D, Kandimalla ER, Agrawal S,. Self-stabilized CpG DNAs optimally activate human B cells and plasmacytoid dendritic cells. Biochem Biophys Res Commun 2003; 310: 1133-1139.
33. Kemp TJ, Elzey BD, Griffith TS,. Plasmacytoid dendritic cell-derived IFN-α induces TNF-related apoptosis-inducing ligand/Apo-2L-mediated antitumor activity by human monocytes following CpG oligodeoxynucleotide stimulation. J Immunol 2003; 171: 212-218.
34. Meng Z, Shao J, Xiang L,. CpG oligodeoxynucleotides activate grass carp (Ctenopharyngodon idellus) macrophages. Dev Comp Immunol 2003; 27: 313-321.
35. Dobrovolskaia MA, McNeil SE,. Immunological properties of engineered nanomaterials. Nat Nanotechnol 2007; 2: 469-478.